Dr. Huda Zoghbi named the 2022 Kavli Prize Laureate in neuroscience
Dr. Zoghbi is being recognized for two discoveries – ATAXIN1, the gene responsible for spinocerebellar ataxia 1, and MECP2, the gene responsible for Rett syndrome.
Read More
Search Results for: Zoghbi
Huda Zoghbi honored with prestigious Breakthrough Prize
Dr. Huda Zoghbi, pioneering neurologist at Baylor College of Medicine and Texas Children’s Hospital, was awarded a prestigious Breakthrough Prize in Life Sciences at a
Read More
Healthy Habits: Dr. Huda Zoghbi jogs, hikes to improve fitness
Taking care of your health is a priority and nobody knows that more than physicians and healthcare providers. It can sometimes be difficult to find
Read More
Huda Zoghbi: A lab of her own
Immigrants make the journey to the United States for a number of reasons. For physician and medical researcher Huda Zoghbi, her journey began with a
Read More
Dr. Margaret Goodell elected to the National Academy of Sciences
Dr. Margaret (“Peggy”) Goodell, an expert in the field of stem cell research, is recognized for her distinguished career and continuing achievements in original scientific work.
Read More
AI accelerates the discovery of genes associated with neurodevelopmental disorders
The researchers hope that their models will also lead to patient diagnoses, and future studies will assess this possibility.
Read More
Understanding the cascade of molecular events leading to Rett syndrome
Characterizing the trajectory of molecular events leading to Rett syndrome opens new opportunities for novel therapeutic approaches.
Read More
How tau becomes a ‘bad guy’ that contributes to Alzheimer’s disease
The findings suggest a strategy to lower tau levels and explore the potential effects in Alzheimer’s disease and tau-induced dementias.
Read More
New mouse model mimics progression of Parkinson’s disease
This model can help identify new disease biomarkers and test therapies that could alter its progression, maybe even prevent the condition.
Read More
Rett patients receive a new gene therapy treatment at Texas Children’s Hospital and Baylor College of Medicine
Nearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read More